U.S. market Open. Closes in 1 hour 29 minutes

AVXL | Anavex Life Sciences Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses55.76M50.99M41.95M30.94M28.81M19.18M15.54M14.88M7.11M2.97M2.13M4.32M6.18M5.64M4.73M5.27M1.58M25.59KN/AN/A
Selling, General & Admin12.04M13.07M9.02M5.86M6.85M5.99M5.01M8.33M4.84M2.24M1.87M1.66M3.57M2.91M2.59M3.79M618.22K25.48K91.54KN/A
Research & Development43.72M37.92M32.98M25.23M22.26M13.34M10.67M7.25M2.27M732.39K263.85K2.65M2.60M2.73M2.14M1.48M959.70KN/AN/AN/A
Other Operating Expenses2.72M3.32M-54.10K-149.89K-298.94K1.63M-140.94K-712.29KN/AN/A576.001.86K10.36K910.00410.00220.00N/A115.00N/AN/A
Operating Income-47.50M-54.40M-41.92M-30.76M-28.75M-19.18M-15.54M-14.88M-7.11M-2.97M-2.13M-4.32M-6.18M-5.64M-4.73M-5.27M-1.58M-25.59K-91.54K-14.47K
Other Expenses / Income2.68M6.78M4.28M4.50M2.54M1.58M2.14M169.67K-5.00M-8.40M-1.57M-3.84M-1.04M-2.85M-707.63K-9.77K1.24K59.00125.00N/A
Before Tax Income-47.50M-47.62M-37.64M-26.26M-26.21M-17.38M-13.40M-14.71M-12.11M-11.37M-3.70MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-7.00K358.49K267.56K22.66K82.18K72.75K59.61K29.61KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-47.49M-47.98M-37.91M-26.28M-26.29M-17.45M-13.46M-14.74M-12.11M-11.37M-3.70M-8.30M-7.31M-8.78M-5.50M-5.35M-1.58M-25.53K-91.62K-14.39K
Interest Expenses964.00K946.99KN/AN/A151.13KN/AN/AN/A71.83K7.09K51.34K144.30K90.25K291.83K57.86KN/AN/AN/AN/AN/A
Basic Shares Outstanding79.79M76.91M69.80M58.19M48.91M44.66M40.84M35.15M18.58M9.93M7.98M7.04M6.29M5.36M5.05M4.93M4.80M4.80M4.35M1.91M
Diluted Shares Outstanding79.79M76.91M69.80M58.19M48.91M44.66M40.84M35.15M18.58M9.93M7.98M7.04M6.29M5.36M5.05M4.93M4.80M4.80M4.35M1.91M
EBITDA-47.50M-50.08M-41.68M-31.06M-28.88M-19.13M-15.57M-14.88M-7.11M-2.97M-2.13M-4.31M-6.18M-5.64M-4.73M-5.27M-1.58M-25.65K-91.67K-14.47K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-46.53M-46.67M-37.64M-26.26M-26.06M-17.38M-13.40M-14.71M-12.04M-11.36M-3.65M-8.16M-7.22M-8.49M-5.44M-5.35M-1.58M-25.53K-91.62K-14.39K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙